Counterintuitively, we observed that kidneys in which the endogenous Nrf2 antioxidant signaling pathway was markedly upregulated after cisplatin administration resulted in worse AKI outcomes compared to kidneys in which Nrf2 pathway activity remained at baseline after JP4-039 treatment. Here, NFE2L2 is linked to acute kidney injury.